Statements of Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statements of Comprehensive Loss [Abstract]
Sales	$ 321,405	$ 329,775
Cost of sales	122,675	93,042
Gross margin	198,730	236,733
Operating expenses:
Research and development	1,421,063	995,022
Sales and marketing	68,863	22,819
General and administrative	1,447,355	891,987
Depreciation and amortization	144,199	153,453
Total operating expenses	3,081,480	2,063,281
Loss from operations	(2,882,750)	(1,826,548)
Other income (expense):
Interest income, net	2,454	164
Interest expense	(2,734)	(3,848)
Other expense, net	(280)	(3,684)
Net loss	(2,883,030)	(1,830,232)
Net loss attributable to common stockholders, basic (in dollars per share)	(2,883,030)	(1,830,232)
Net loss attributable to common stockholders, diluted (in dollars per share)	$ (2,883,030)	$ (1,830,232)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.24)	$ (1.84)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.24)	$ (1.84)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	11,804,165	995,208
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	11,804,165	995,208